Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study

Table 3 Prognostic determinants of LTFU among clients on ART in Gondar Town from October 2016 to April 2021

Prognostic variables	LTFU		Bi-variable	Multivariable
Prognostic variables	No	Yes	COR (95% CI)	AOR (95% CI)
Partner HIV status
Known status	111	16	1
Unknown status	210	95	3.14 (1.81–5.77)
Prophylaxis status
Yes	244	37	1	1
No	77	74	6.34 (3.99–10.23)	2.82 (1.58–5.03)**
ASM
Not ASM	71	4	1	1
ASM	250	107	7.59 (3.05–25.40)	4.92 (1.52–15.94)*
Adherence status
Good	270	47	1	1
Poor	51	64	7.21 (4.48–11.74)	3.07 (1.70–5.57)***
Date of ART initiation
Same day	189	80	1
Not same day	132	31	0.55 (0.35–0.89)
Marital status
Married	146	25	1
Unmarried	175	86	2.87 (1.75–4.72)
HIV disclosure status
Yes	156	80	1
No	165	31	0.37 (0.23–0.59)
BMI
Underweight	89	23	1	1
Normal	191	77	1.56 (0.92–2.65)	2.75 (1.43–5.30)
Obese	41	11	1.04 (0.46–2.33)
Residence
Urban	265	86	1	1
Rural	56	25	1.44 (0.83–2.42)	2.20 (1.11–4.39)*
Care giver
Yes	298	91	1
No	23	20	2.84 (1.48–5.42)
HVL status
Not HVL	253	29	1	1
HVL	68	82	10.52 (6.45–17.59)	4.54 (2.43–8.47)***

^*** = Significant at p-value < 0.001, * = significant at p-value < 0.05
COR Crude odds ratio, AOR adjusted odds ratio, CI confidence interval, LTFU lost to follow-up, ASM Appointment spacing model, TB tuberculosis, HIV human immunodeficiency virus, WHO World Health Organization, BMI Body Mass Index, ART antiretroviral therapy, OI opportunistic infection, HVL high viral load

ISSN: 1471-2334